Atlas Trials

Phase II Study of Irinotecan and Cisplatin in Extensive-stage Small Cell Lung Cancer

Clinical trial NCT02323737 · COMPLETED

Trial details

NCT number
NCT02323737
Sponsor
Chinese Academy of Medical Sciences
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Extensive-stage Small Cell Lung Cancer
Start date
2010-07-01
Primary completion
2011-06-01
Enrollment
62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.